InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.73
(
1.03%
)
US TECH 100
17,575.20
(
0.90%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.32
(
0.23%
)
Bitcoin
63,181.01
(
-1.28%
)
Post# of 642318
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

crudeoil24

Send PM Follow Ignore
Followers 800
Posts 50862
Boards Moderated 2
Alias Born 12/12/2004

crudeoil24

Member Level

Re: crudeoil24 post# 417821

Friday, 03/22/2019 4:47:23 PM

Friday, March 22, 2019 4:47:23 PM

Post# of 642318
SNSS > CONFIDENTIAL TREATMENT filing with SEC, March 18, 2019. Targeting a mechanism of resistance to first-generation BTK inhibitors caught the attention of biotechs, which is claiming major success this month. Big pharma also involved. Bank of America and Merrill Lynch, BTK inhibitor market potential is huge, ~$16B

New York Yankees and Duke Basketball

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up